Annual FCF
-$25.87 M
+$24.05 M+48.18%
March 31, 2024
Summary
- As of February 8, 2025, VTGN annual free cash flow is -$25.87 million, with the most recent change of +$24.05 million (+48.18%) on March 31, 2024.
- During the last 3 years, VTGN annual FCF has fallen by -$13.53 million (-109.52%).
- VTGN annual FCF is now -374885.51% below its all-time high of -$6900.00, reached on December 31, 2010.
Performance
VTGN Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$10.95 M
-$36.00 K-0.33%
September 30, 2024
Summary
- As of February 8, 2025, VTGN quarterly free cash flow is -$10.95 million, with the most recent change of -$36.00 thousand (-0.33%) on September 30, 2024.
- Over the past year, VTGN quarterly FCF has stayed the same.
- VTGN quarterly FCF is now -1309.75% below its all-time high of $904.90 thousand, reached on September 30, 2020.
Performance
VTGN Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$33.65 M
-$4.76 M-16.46%
September 30, 2024
Summary
- As of February 8, 2025, VTGN TTM free cash flow is -$33.65 million, with the most recent change of -$4.76 million (-16.46%) on September 30, 2024.
- Over the past year, VTGN TTM FCF has stayed the same.
- VTGN TTM FCF is now -11216900.00% below its all-time high of -$300.00, reached on March 31, 2008.
Performance
VTGN TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
VTGN Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +48.2% | 0.0% | 0.0% |
| 3 y3 years | -109.5% | 0.0% | 0.0% |
| 5 y5 years | -76.0% | 0.0% | 0.0% |
VTGN Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -109.5% | +48.2% | -139.7% | +33.1% | -30.1% | +44.0% |
| 5 y | 5-year | -109.5% | +48.2% | -1309.8% | +33.1% | -284.1% | +44.0% |
| alltime | all time | <-9999.0% | +48.2% | -1309.8% | +33.1% | <-9999.0% | +44.0% |
VistaGen Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$10.95 M(+0.3%) | -$33.65 M(+16.5%) |
| Jun 2024 | - | -$10.91 M(+51.0%) | -$28.89 M(+11.7%) |
| Mar 2024 | -$25.87 M(-48.2%) | -$7.23 M(+58.2%) | -$25.87 M(-0.9%) |
| Dec 2023 | - | -$4.57 M(-26.2%) | -$26.12 M(-17.1%) |
| Sep 2023 | - | -$6.19 M(-21.6%) | -$31.50 M(-24.4%) |
| Jun 2023 | - | -$7.89 M(+5.6%) | -$41.68 M(-16.5%) |
| Mar 2023 | -$49.93 M(+9.8%) | -$7.47 M(-24.9%) | -$49.93 M(-14.0%) |
| Dec 2022 | - | -$9.95 M(-39.2%) | -$58.04 M(-3.5%) |
| Sep 2022 | - | -$16.37 M(+1.4%) | -$60.14 M(+8.8%) |
| Jun 2022 | - | -$16.14 M(+3.6%) | -$55.28 M(+21.6%) |
| Mar 2022 | -$45.46 M(+268.1%) | -$15.59 M(+29.4%) | -$45.46 M(+29.2%) |
| Dec 2021 | - | -$12.05 M(+4.7%) | -$35.18 M(+24.4%) |
| Sep 2021 | - | -$11.50 M(+81.9%) | -$28.27 M(+78.2%) |
| Jun 2021 | - | -$6.32 M(+19.1%) | -$15.87 M(+28.5%) |
| Mar 2021 | -$12.35 M(-21.6%) | -$5.31 M(+3.3%) | -$12.35 M(+28.4%) |
| Dec 2020 | - | -$5.14 M(-668.0%) | -$9.62 M(+9.8%) |
| Sep 2020 | - | $904.90 K(-132.2%) | -$8.76 M(-36.5%) |
| Jun 2020 | - | -$2.81 M(+8.8%) | -$13.80 M(-12.4%) |
| Mar 2020 | -$15.76 M(+7.2%) | -$2.58 M(-39.7%) | -$15.76 M(-5.9%) |
| Dec 2019 | - | -$4.28 M(+3.5%) | -$16.74 M(+2.3%) |
| Sep 2019 | - | -$4.14 M(-13.1%) | -$16.37 M(+0.5%) |
| Jun 2019 | - | -$4.76 M(+33.7%) | -$16.29 M(+10.8%) |
| Mar 2019 | -$14.70 M(+62.3%) | -$3.56 M(-8.9%) | -$14.70 M(+7.0%) |
| Dec 2018 | - | -$3.91 M(-3.8%) | -$13.74 M(+11.9%) |
| Sep 2018 | - | -$4.06 M(+28.1%) | -$12.28 M(+21.6%) |
| Jun 2018 | - | -$3.17 M(+21.8%) | -$10.10 M(+11.4%) |
| Mar 2018 | -$9.06 M(+20.8%) | -$2.60 M(+6.5%) | -$9.06 M(+13.5%) |
| Dec 2017 | - | -$2.44 M(+30.2%) | -$7.98 M(+4.6%) |
| Sep 2017 | - | -$1.88 M(-12.0%) | -$7.63 M(-4.1%) |
| Jun 2017 | - | -$2.13 M(+40.1%) | -$7.96 M(+6.1%) |
| Mar 2017 | -$7.50 M(+55.2%) | -$1.52 M(-27.4%) | -$7.50 M(+2.6%) |
| Dec 2016 | - | -$2.10 M(-5.0%) | -$7.31 M(+14.5%) |
| Sep 2016 | - | -$2.21 M(+32.0%) | -$6.39 M(+12.3%) |
| Jun 2016 | - | -$1.67 M(+25.7%) | -$5.68 M(+17.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | -$4.83 M(+74.6%) | -$1.33 M(+13.4%) | -$4.83 M(+9.9%) |
| Dec 2015 | - | -$1.17 M(-22.1%) | -$4.40 M(+23.4%) |
| Sep 2015 | - | -$1.51 M(+82.9%) | -$3.56 M(+38.2%) |
| Jun 2015 | - | -$823.30 K(-8.0%) | -$2.58 M(-6.8%) |
| Mar 2015 | -$2.77 M(+29.7%) | -$894.50 K(+162.3%) | -$2.77 M(+18.3%) |
| Dec 2014 | - | -$341.00 K(-34.6%) | -$2.34 M(+1.0%) |
| Sep 2014 | - | -$521.60 K(-48.4%) | -$2.32 M(-3.6%) |
| Jun 2014 | - | -$1.01 M(+116.6%) | -$2.41 M(+12.7%) |
| Mar 2014 | -$2.14 M(-40.7%) | -$467.10 K(+46.7%) | -$2.14 M(-19.2%) |
| Dec 2013 | - | -$318.40 K(-47.7%) | -$2.64 M(-22.7%) |
| Sep 2013 | - | -$608.70 K(-17.9%) | -$3.42 M(-15.5%) |
| Jun 2013 | - | -$741.40 K(-23.9%) | -$4.04 M(+12.4%) |
| Mar 2013 | -$3.60 M(+0.0%) | -$974.30 K(-10.9%) | -$3.60 M(+7.0%) |
| Dec 2012 | - | -$1.09 M(-11.4%) | -$3.36 M(+0.9%) |
| Sep 2012 | - | -$1.23 M(+316.7%) | -$3.33 M(+18.7%) |
| Jun 2012 | - | -$296.20 K(-59.8%) | -$2.81 M(-22.0%) |
| Mar 2012 | -$3.60 M(>+9900.0%) | -$737.60 K(-30.7%) | -$3.60 M(+25.7%) |
| Dec 2011 | - | -$1.06 M(+49.9%) | -$2.86 M(+59.0%) |
| Sep 2011 | - | -$710.00 K(-34.7%) | -$1.80 M(+65.1%) |
| Jun 2011 | - | -$1.09 M(>+9900.0%) | -$1.09 M(>+9900.0%) |
| Mar 2011 | - | -$1700.00(-19.0%) | -$8600.00(+24.6%) |
| Dec 2010 | -$6900.00(-69.7%) | -$2100.00(+2000.0%) | -$6900.00(-5.5%) |
| Sep 2010 | - | -$100.00(-97.9%) | -$7300.00(+1.4%) |
| Jun 2010 | - | -$4700.00(<-9900.0%) | -$7200.00(+50.0%) |
| Mar 2010 | - | $0.00(-100.0%) | -$4800.00(-78.9%) |
| Dec 2009 | -$22.80 K(+45.2%) | -$2500.00(<-9900.0%) | -$22.80 K(-33.5%) |
| Sep 2009 | - | $0.00(-100.0%) | -$34.30 K(-0.3%) |
| Jun 2009 | - | -$2300.00(-87.2%) | -$34.40 K(+6.8%) |
| Mar 2009 | - | -$18.00 K(+28.6%) | -$32.20 K(+122.1%) |
| Dec 2008 | -$15.70 K | -$14.00 K(>+9900.0%) | -$14.50 K(+2800.0%) |
| Sep 2008 | - | -$100.00(0.0%) | -$500.00(+25.0%) |
| Jun 2008 | - | -$100.00(-66.7%) | -$400.00(+33.3%) |
| Mar 2008 | - | -$300.00(-86.4%) | -$300.00(-86.4%) |
| Mar 2007 | - | -$2200.00 | -$2200.00 |
FAQ
- What is VistaGen Therapeutics annual free cash flow?
- What is the all time high annual FCF for VistaGen Therapeutics?
- What is VistaGen Therapeutics annual FCF year-on-year change?
- What is VistaGen Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for VistaGen Therapeutics?
- What is VistaGen Therapeutics quarterly FCF year-on-year change?
- What is VistaGen Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for VistaGen Therapeutics?
- What is VistaGen Therapeutics TTM FCF year-on-year change?
What is VistaGen Therapeutics annual free cash flow?
The current annual FCF of VTGN is -$25.87 M
What is the all time high annual FCF for VistaGen Therapeutics?
VistaGen Therapeutics all-time high annual free cash flow is -$6900.00
What is VistaGen Therapeutics annual FCF year-on-year change?
Over the past year, VTGN annual free cash flow has changed by +$24.05 M (+48.18%)
What is VistaGen Therapeutics quarterly free cash flow?
The current quarterly FCF of VTGN is -$10.95 M
What is the all time high quarterly FCF for VistaGen Therapeutics?
VistaGen Therapeutics all-time high quarterly free cash flow is $904.90 K
What is VistaGen Therapeutics quarterly FCF year-on-year change?
Over the past year, VTGN quarterly free cash flow has changed by $0.00 (0.00%)
What is VistaGen Therapeutics TTM free cash flow?
The current TTM FCF of VTGN is -$33.65 M
What is the all time high TTM FCF for VistaGen Therapeutics?
VistaGen Therapeutics all-time high TTM free cash flow is -$300.00
What is VistaGen Therapeutics TTM FCF year-on-year change?
Over the past year, VTGN TTM free cash flow has changed by $0.00 (0.00%)